May 24, 2022 9:00 am EDT Know Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA Clearance Application
Apr 05, 2022 9:00 am EDT New Foundational Patents Secure Multiple Growth Opportunities for Know Labs and Its Bio-RFID™ Non-Invasive Diagnostic Technology
Mar 08, 2022 9:00 am EST Know Labs Provides 2022 Outlook, Outlines Preparations for Pre-Submission Meeting with FDA
Feb 03, 2022 9:00 am EST Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™
Dec 16, 2021 9:00 am EST Know Labs Launches Subsidiary, AI Mind Inc., Generates $4.2M in NFT Revenue to Fund Continued Non-Invasive Glucose Monitoring Device Development
Oct 13, 2021 9:00 am EDT New Test Data Confirm Particle™ Bulb from Know Labs Successfully Inactivates SARS-CoV-2 Variants
Oct 06, 2021 9:00 am EDT New Tests Show Know Labs Bio-RFID™ Technology Delivers Blood Glucose Readings Comparable to FDA-Cleared Devices
Sep 22, 2021 9:00 am EDT Know Labs Expands Non-Invasive Glucose Monitoring Product Portfolio with Introduction of New KnowU™ Diagnostic Device
Jul 27, 2021 9:00 am EDT Three New Patents for Know Labs Expand IP Portfolio and Signal Further Applications for Bio-RFID™
Jul 14, 2021 9:00 am EDT New Patent for Know Labs Marks Latest Step Toward Commercial Launch of Bio-RFIDTM Non-Invasive Medical Diagnostic Technology